Conversely, GM-CSF upregulation was found to be associated with increased aggressiveness of various tumor types including bladder cancer (52, 53), colorectal carcinoma (54), glioblastomas (55) and head and neck cancers (56). This evidence concerns the gene CSF2 and head and neck cancer.